Literature DB >> 15338046

Chromosomal regulation by MeCP2: structural and enzymatic considerations.

N J Bowen1, M B Palmer, P A Wade.   

Abstract

The unique properties of eukaryotic DNA modified via methylation of cytosine residues are believed to result from the action of a conserved family of proteins, the MBD family. The prototype member of this family, MeCP2, was isolated independently in two laboratories. One group isolated MeCP2 as a methylated DNA-binding protein, the second as a sequence-specific DNA-binding protein. Multiple lines of evidence suggest that MeCP2 functions in assembly of specialized chromatin architecture. While initial findings pointed to an enzymatic mechanism involving histone modification for transcriptional repression mediated by MeCP2, emerging studies clearly provide exceptions to this model. In a recent study, highly compacted, unique chromatin structures were generated by stoichiometric binding of MeCP2 to model chromatin fibers. These findings support the likelihood that MeCP2 can utilize two independent, but not mutually exclusive, mechanisms to repress transcription: enzymatic and structural mechanisms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15338046     DOI: 10.1007/s00018-004-4177-x

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  23 in total

1.  2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology.

Authors:  Ornella Leone; John P Veinot; Annalisa Angelini; Ulrik T Baandrup; Cristina Basso; Gerald Berry; Patrick Bruneval; Margaret Burke; Jagdish Butany; Fiorella Calabrese; Giulia d'Amati; William D Edwards; John T Fallon; Michael C Fishbein; Patrick J Gallagher; Marc K Halushka; Bruce McManus; Angela Pucci; E René Rodriguez; Jeffrey E Saffitz; Mary N Sheppard; Charles Steenbergen; James R Stone; Carmela Tan; Gaetano Thiene; Allard C van der Wal; Gayle L Winters
Journal:  Cardiovasc Pathol       Date:  2011-12-03       Impact factor: 2.185

Review 2.  [Myocardial fibrosis: a cardiopathophysiologic Janus head].

Authors:  Bernhard Maisch; Heinz Rupp
Journal:  Herz       Date:  2006-05       Impact factor: 1.443

3.  The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology.

Authors:  Leslie T Cooper; Kenneth L Baughman; Arthur M Feldman; Andrea Frustaci; Mariell Jessup; Uwe Kuhl; Glenn N Levine; Jagat Narula; Randall C Starling; Jeffrey Towbin; Renu Virmani
Journal:  Eur Heart J       Date:  2007-10-24       Impact factor: 29.983

Review 4.  Cardiomyopathies: classification, diagnosis, and treatment.

Authors:  Bernhard Maisch; Michel Noutsias; Volker Ruppert; Anette Richter; Sabine Pankuweit
Journal:  Heart Fail Clin       Date:  2012-01       Impact factor: 3.179

Review 5.  Genetics and metabolic cardiomyopathies.

Authors:  E C Wicks; P M Elliott
Journal:  Herz       Date:  2012-09       Impact factor: 1.443

Review 6.  Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy.

Authors:  B Maisch; S Pankuweit
Journal:  Herz       Date:  2012-09       Impact factor: 1.443

7.  Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance.

Authors:  Ali Yilmaz; Ingrid Kindermann; Michael Kindermann; Felix Mahfoud; Christian Ukena; Anastasios Athanasiadis; Stephan Hill; Heiko Mahrholdt; Matthias Voehringer; Michael Schieber; Karin Klingel; Reinhard Kandolf; Michael Böhm; Udo Sechtem
Journal:  Circulation       Date:  2010-08-16       Impact factor: 29.690

8.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

Authors:  Perry Elliott; Bert Andersson; Eloisa Arbustini; Zofia Bilinska; Franco Cecchi; Philippe Charron; Olivier Dubourg; Uwe Kühl; Bernhard Maisch; William J McKenna; Lorenzo Monserrat; Sabine Pankuweit; Claudio Rapezzi; Petar Seferovic; Luigi Tavazzi; Andre Keren
Journal:  Eur Heart J       Date:  2007-10-04       Impact factor: 29.983

9.  The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes.

Authors:  A Pelliccia; B J Maron; A Spataro; M A Proschan; P Spirito
Journal:  N Engl J Med       Date:  1991-01-31       Impact factor: 91.245

10.  Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy.

Authors:  Holger Vogelsberg; Heiko Mahrholdt; Claudia C Deluigi; Ali Yilmaz; Eva M Kispert; Simon Greulich; Karin Klingel; Reinhard Kandolf; Udo Sechtem
Journal:  J Am Coll Cardiol       Date:  2008-03-11       Impact factor: 24.094

View more
  14 in total

1.  Molecular control of nuclear and subnuclear targeting of the plant CDK inhibitor ICK1 and ICK1-mediated nuclear transport of CDKA.

Authors:  Yongming Zhou; Hesheng Niu; Federica Brandizzi; Larry C Fowke; Hong Wang
Journal:  Plant Mol Biol       Date:  2006-07-15       Impact factor: 4.076

Review 2.  Evolving role of MeCP2 in Rett syndrome and autism.

Authors:  Janine M LaSalle; Dag H Yasui
Journal:  Epigenomics       Date:  2009-10       Impact factor: 4.778

3.  Activation and repression domains within the promoter of the rat cathepsin L gene orchestrate sertoli cell-specific and stage-specific gene transcription in transgenic mice.

Authors:  Thomas Visone; Martin Charron; William W Wright
Journal:  Biol Reprod       Date:  2009-05-20       Impact factor: 4.285

4.  Epigenetic mechanisms and genome stability.

Authors:  Emily L Putiri; Keith D Robertson
Journal:  Clin Epigenetics       Date:  2011-08-01       Impact factor: 6.551

5.  A trial of somatic gene targeting in vivo with an adenovirus vector.

Authors:  Asami Ino; Yasuhiro Naito; Hiroyuki Mizuguchi; Naofumi Handa; Takao Hayakawa; Ichizo Kobayashi
Journal:  Genet Vaccines Ther       Date:  2005-10-12

6.  Using epigenomics data to predict gene expression in lung cancer.

Authors:  Jeffery Li; Travers Ching; Sijia Huang; Lana X Garmire
Journal:  BMC Bioinformatics       Date:  2015-03-18       Impact factor: 3.169

Review 7.  Targeting mitotic chromosomes: a conserved mechanism to ensure viral genome persistence.

Authors:  Katherine M Feeney; Joanna L Parish
Journal:  Proc Biol Sci       Date:  2009-01-20       Impact factor: 5.349

8.  MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines.

Authors:  Mario Dandrea; Massimo Donadelli; Chiara Costanzo; Aldo Scarpa; Marta Palmieri
Journal:  Nucleic Acids Res       Date:  2009-09-10       Impact factor: 16.971

9.  Sex, stress, and epigenetics: regulation of behavior in animal models of mood disorders.

Authors:  Georgia E Hodes
Journal:  Biol Sex Differ       Date:  2013-01-21       Impact factor: 5.027

10.  Permissive transcriptional activity at the centromere through pockets of DNA hypomethylation.

Authors:  Nicholas C Wong; Lee H Wong; Julie M Quach; Paul Canham; Jeffrey M Craig; Jenny Z Song; Susan J Clark; K H Andy Choo
Journal:  PLoS Genet       Date:  2006-02-10       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.